Biotech · Private company
Impel Pharmaceuticals
Track this companyFree. Adds Impel Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- INP104Phase 3 · Migraine HeadacheClinicalTrials.gov · fetched Nov 12, 2026
- INP105Phase 2 · Agitation in Adolescents and Young Adults With ASDClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- INP105 Proof-of-concept Study for the Acute Treatment of Agitation in Adolescents and Young Adults With ASDPHASE2 · TERMINATED · started Jun 23, 2022ClinicalTrials.gov NCT05163717 · fetched Nov 12, 2026
- Safety and Tolerability of POD-DHE (INP104) in Migraine (STOP 301)PHASE3 · COMPLETED · started Jul 13, 2018ClinicalTrials.gov NCT03557333 · fetched Nov 12, 2026